The need for better evidence for the use of Botulinum toxin A (BoNT‐A) in the treatment of children with CP: Lessons from Norway

Publisher: John Wiley & Sons Inc

E-ISSN: 1469-8749|58|S5|27-27

ISSN: 0012-1622

Source: DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol.58, Iss.S5, 2016-09, pp. : 27-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content